More than 40% of nursing home residents in the U.S have Alzheimer’s disease, dementia or cognitive impairment, according to a new report that highlights targeted changes that can improve the quality of care at facilities.
The family of a dementia patient is able to move forward with a lawsuit against a state-owned nursing home, involving allegations of improper use of drugs as chemical restraints
Even though rates of dementia diagnoses dropped worldwide during the COVID-19 pandemic, rates of prescribing antipsychotics to those patients increased, raising fears the drugs are being used as chemical restraints.
Tactics which worked to reduce the use of chemical restraints in nursing homes failed to produce similar results at assisted living facilities, researchers found.
Understaffing in nursing homes has been identified as a serious issue, but the industry is pushing back against reforms intended to improve the quality of care
